Trial intelligence / Profile preview

Metronomic Combination Therapy in Children and Adolescents With Relapsed or Progressing Solid Tumours

NCT01285817Phase 2Completed

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Jan 2011
Primary completion
Sep 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of celecoxib, vinblastine, cyclophosphamide, methotrexate in solid tumor, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Jan 2011; status: completed.

02

Drugs

celecoxibvinblastinecyclophosphamidemethotrexate
03

Conditions

solid tumor

Beyond the preview

Go deeper on NCT01285817.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01285817.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call